No Data
No Data
Catalyst Pharmaceuticals(CPRX.US) Officer Sells US$4.89 Million in Common Stock
Express News | Form 144 | Catalyst Pharmaceuticals(CPRX.US) Officer Proposes to Sell 3.9 Million in Common Stocks
Catalyst Pharmaceuticals' (NASDAQ:CPRX) Solid Earnings Are Supported By Other Strong Factors
Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
Catalyst Pharmaceuticals Is Maintained at Outperform by Baird
Baird Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating, Raises Target Price to $32